The application relates to a vascular embolic system comprising compositions comprising solutions of specific peptides for use in the treatment of three different conditions, namely (i) cancer, (ii) patent ductus arteriosus (PDA) or (iii) major aortopulmonary collateral artery (MAPCA).
Brief outline of the case
The applicant appealed the refusal for lack of N.